Pocketing $3.7M, Eureka Touts Informatics as Differentiator in Sequencing Services, Microorganism Detection | GenomeWeb

By Bernadette Toner

Fresh from a $3.7 million financing round, Eureka Genomics is looking to build out both sides of its two-pronged business model, which involves sequencing services as well as internal discovery projects to identify novel microorganisms associated with disease.

Underlying this hybrid model is a portfolio of proprietary bioinformatics tools that the company licensed in 2007 from the University of Houston.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Science this week: Neanderthal-derived DNA linked to modern ailments, and more.

Japan needs to catch up on its gene-editing research efforts, the Japan News writes.

Hundreds of people have signed an online petition calling for zero tolerance to sexual harassment in the sciences.

Jeff Huber, former Google X senior vice president, joins Grail as its CEO.

Feb
25
Sponsored by
Omicia

This webinar will demonstrate how ACMG's recommended variant scoring and classification rules may be applied to standardize reporting on sequencing test results within and across institutions.